You have 9 free searches left this month | for more free features.

clofarabine

Showing 26 - 50 of 123

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Malignant Hematologic Disorders Trial in New York (Melphalan, Thiotepa, Clofarabine)

Terminated
  • Non-Malignant Hematologic Disorders
  • New York, New York
    Memorial SloanKettering Cancer Center
Mar 1, 2021

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (radiation, drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +3 more
  • total body irradiation
  • +7 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 17, 2021

Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)

Completed
  • Leukemia
  • Clofarabine
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 17, 2020

Myeloid Malignancy, Bone Marrow Failure Syndrome, Transfusion-dependent Red Blood Cell (RBC) Defect Trial in San Francisco

Terminated
  • Myeloid Malignancy
  • +5 more
  • San Francisco, California
    University of California, San Francisco
Feb 25, 2020

Acute Myeloid Leukemia Trial in Aurora, New Orleans, Seattle (procedure, drug, other, radiation)

Completed
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Aurora, Colorado
  • +3 more
Apr 3, 2020

Lymphoma Trial in Portland (biological, drug, genetic, other)

Terminated
  • Lymphoma
  • rituximab
  • +7 more
  • Portland, Oregon
    Knight Cancer Institute at Oregon Health and Science University
Nov 15, 2019

Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia Trial in Columbus, Madison, Milwaukee (Clofarabine, Cyclophosphamide,

Terminated
  • Leukemia, Acute Lymphoblastic
  • Acute Myeloid Leukemia
  • Clofarabine
  • +2 more
  • Columbus, Ohio
  • +3 more
Feb 18, 2020

Myeldysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia, Bone Marrow Diseases Trial run by the NHLBI (Clofarabine,

Completed
  • Myeldysplastic Syndrome (MDS)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Leukemia Trial in Hershey (Clofarabine, Mitoxantrone, Etoposide)

Terminated
  • Leukemia
  • Clofarabine
  • +2 more
  • Hershey, Pennsylvania
    Penn State Hershey Cancer Institute
Jul 22, 2019

Acute Myelogenous Leukemia Trial in Houston (Plerixafor, Clofarabine)

Terminated
  • Acute Myelogenous Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 19, 2019

Leukemia Trial in Houston (Decitabine, Idarubicin, Cytarabine)

Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 28, 2019

Myelodysplastic Syndrome, Leukemia Trial in Houston (procedure, drug, other, radiation)

Completed
  • Myelodysplastic Syndrome
  • Leukemia
  • Cord Blood Infusion
  • +11 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 27, 2020

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia

Active, not recruiting
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +16 more
  • clofarabine
  • +7 more
  • Birmingham, Alabama
  • +268 more
Feb 23, 2021

Recurrent Aggressive Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Burkitt Lymphoma Trial in Houston

Not yet recruiting
  • Recurrent Aggressive Non-Hodgkin Lymphoma
  • +6 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 6, 2020

Adrenoleukodystrophy, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy Trial in Minneapolis (drug, procedure,

Completed
  • Adrenoleukodystrophy
  • +8 more
  • Clofarabine
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jul 10, 2019

Myelodysplastic Syndrome Trial in Houston (Decitabine, Clofarabine)

Completed
  • Myelodysplastic Syndrome
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 17, 2018

Leukemia, Myeloid, MDS Trial in Houston (clofarabine, Ara-C)

Completed
  • Leukemia, Myeloid
  • Myelodysplastic Syndromes
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
Nov 5, 2018

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +17 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 27, 2019

Acute Myeloid Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)

Completed
  • Acute Myeloid Leukemia
  • Clofarabine
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 10, 2018

Acute Myeloid Leukaemia, Myelodysplasia Trial in Southampton (Clofarabine)

Completed
  • Acute Myeloid Leukaemia
  • Myelodysplasia
  • Clofarabine
  • Southampton, Hampshire, United Kingdom
    Wessex Blood and Marrow Transplant Unit, Southampton University
Sep 5, 2018

Leukemia Trial in Houston (drug, radiation, biological)

Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 22, 2019

Leukemia Trial in Winston-Salem (clofarabine, cytarabine)

Completed
  • Leukemia
  • Winston-Salem, North Carolina
    Wake Forest University Comprehensive Cancer Center
Aug 8, 2018

Leukemia, Lymphoma, Allogeneic Haematopoietic Stem Cell Transplantation Trial in Houston (Busulfan, Clofarabine, Thymoglobulin)

Completed
  • Leukemia
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 11, 2018

Leukemia, Myeloproliferative Diseases Trial in Houston (Clofarabine, Cytarabine)

Completed
  • Leukemia
  • Myeloproliferative Diseases
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 5, 2018